T Cell Vaccinology: Beyond the Reflection of Infectious Responses

Trends Immunol. 2016 Mar;37(3):170-180. doi: 10.1016/j.it.2016.01.001. Epub 2016 Jan 30.

Abstract

Inducing sustained, robust CD8(+) T cell responses is necessary for therapeutic intervention in chronic infectious diseases and cancer. Unfortunately, most adjuvant formulations fail to induce substantial cellular immunity in humans. Attenuated acute infectious agents induce strong CD8(+) T cell immunity, and are thought to therefore represent a good road map for guiding the development of subunit vaccines capable of inducing the same. However, recent evidence suggests that this assumption may need reconsideration. Here we provide an overview of subunit vaccine history as it pertains to instigating T cell responses. We argue that in light of evidence demonstrating that T cell responses to vaccination differ from those induced by infectious challenge, research in pursuit of cellular immunity-inducing vaccine adjuvants should no longer follow only the infection paradigm.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • Cancer Vaccines / immunology*
  • Humans
  • Immunotherapy, Adoptive*
  • Infections / immunology*
  • Lymphocyte Activation
  • Receptors, Tumor Necrosis Factor / immunology
  • Vaccines, Subunit / immunology*

Substances

  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Receptors, Tumor Necrosis Factor
  • Vaccines, Subunit